Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma. Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C*. Proteomics. 2019 Jun;19(12):e1800159.

01 Jun 2019
0

Phosphoproteome Profiling of Isogenic Cancer Cell-Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma.

Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C*.

Proteomics. 2019 Jun;19(12):e1800159.

Tags

Share this

Related Posts

Sungkeeree, P.; Toewiwat, N.; Whangsuk, W.; Ploypradith, P.; Mongkolsuk, S.; Loprasert, S. The Esterase B from Sphingobium sp. SM42 Has the New Dearenethiolase Activity against Cephalosporin Antibiotics. Biochem. Biophys. Res. Commun. 2018, 506, 231–236.
In utero arsenic exposure increases DNA damage and gene expression changes in umbilical cord mesenchymal stem cells (UC-MSCs) from newborns as well as in UC-MSC differentiated hepatocytes. Kantisin, S., Chaisatra, K., Hunsonti, P, Parnlob, V., Navasumrit, P., Ruchirawat, M. Toxicology reports, 9 (2022). 1728-1741. doi: 10.1016/j.toxrep.2022.09.002

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New